And with GLP-1s, we know theres a component of, again, as you said, muscle loss and sarcopenia
Roughly 1 in 8 (12%) consumers have taken a GLP-1 drug , per KFF, and that share is likely to rise: 26% of US consumers plan to take a weight loss drug to achieve their 2025 New Year's resolution goals , per Tebra
Can you microdose semaglutide
Amy Bremner, MD, breast surgical oncologist and medical director of breast surgical oncology at MemorialCare Saddleback Medical Center in Laguna Hills, CA, who wasnt involved in the study, said the findings were promising
Most users who stop MT2 report returning to baseline skin tone within 1216 weeks without intervention